PL1652843T3 - Pochodne amidu - Google Patents

Pochodne amidu

Info

Publication number
PL1652843T3
PL1652843T3 PL04748296T PL04748296T PL1652843T3 PL 1652843 T3 PL1652843 T3 PL 1652843T3 PL 04748296 T PL04748296 T PL 04748296T PL 04748296 T PL04748296 T PL 04748296T PL 1652843 T3 PL1652843 T3 PL 1652843T3
Authority
PL
Poland
Prior art keywords
amide derivatives
amide
derivatives
Prior art date
Application number
PL04748296T
Other languages
English (en)
Inventor
Toru Kontani
Junji Miyata
Wataru Hamaguchi
Tomoaki Kawano
Akio Kamikawa
Hiroshi Suzuki
Kenji Sudo
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of PL1652843T3 publication Critical patent/PL1652843T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
PL04748296T 2003-08-08 2004-08-05 Pochodne amidu PL1652843T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003290850 2003-08-08
PCT/JP2004/011573 WO2005014559A1 (ja) 2003-08-08 2004-08-05 アミド誘導体
EP04748296.3A EP1652843B1 (en) 2003-08-08 2004-08-05 Amide derivatives

Publications (1)

Publication Number Publication Date
PL1652843T3 true PL1652843T3 (pl) 2014-09-30

Family

ID=34114142

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04748296T PL1652843T3 (pl) 2003-08-08 2004-08-05 Pochodne amidu

Country Status (19)

Country Link
US (2) US7465748B2 (pl)
EP (1) EP1652843B1 (pl)
JP (1) JP4549974B2 (pl)
KR (1) KR101157074B1 (pl)
CN (1) CN100445271C (pl)
AU (1) AU2004263448B2 (pl)
BR (1) BRPI0413430B8 (pl)
CA (1) CA2535199C (pl)
CY (1) CY1115461T1 (pl)
DK (1) DK1652843T3 (pl)
ES (1) ES2462292T3 (pl)
MX (1) MXPA06001526A (pl)
NO (1) NO335467B1 (pl)
PL (1) PL1652843T3 (pl)
PT (1) PT1652843E (pl)
RU (1) RU2336273C2 (pl)
SI (1) SI1652843T1 (pl)
TW (1) TW200505894A (pl)
WO (1) WO2005014559A1 (pl)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL370989A1 (pl) * 2001-12-21 2005-06-13 Novo Nordisk A/S Pochodne amidowe jako aktywatory GK
AU2003243921B2 (en) * 2002-06-27 2009-05-07 Novo Nordisk A/S Aryl carbonyl derivatives as therapeutic agents
TW200505894A (en) * 2003-08-08 2005-02-16 Yamanouchi Pharma Co Ltd Tetrahydro-2H-thiopyran-4-carboxamide derivative
BRPI0506662B8 (pt) * 2004-01-06 2021-05-25 Novo Nordisk As compostos ativadores de glucoquinase
JPWO2006082820A1 (ja) * 2005-02-02 2008-06-26 アステラス製薬株式会社 性器ヘルペス治療剤
JPWO2006082822A1 (ja) * 2005-02-02 2008-06-26 アステラス製薬株式会社 アシクロビル耐性ヘルペスウイルスによる疾患の予防・治療剤
US20090042915A1 (en) * 2005-02-02 2009-02-12 Astellas Pharma Inc. Preventive or therapeutic agent for herpesvirus-releated disease
JP5011739B2 (ja) * 2005-02-03 2012-08-29 アステラス製薬株式会社 テトラヒドロ−２ｈ−チオピラン−４−カルボキサミド誘導体を含有する医薬組成物
JP2009500377A (ja) * 2005-07-08 2009-01-08 ノボ・ノルデイスク・エー／エス ジシクロアルキルウレア型グルコキナーゼ活性化剤
EP1904438B1 (en) * 2005-07-08 2012-02-29 Novo Nordisk A/S Dicycloalkylcarbamoyl ureas as glucokinase activators
EP1904467B1 (en) 2005-07-14 2013-05-01 Novo Nordisk A/S Urea glucokinase activators
EP2118083A1 (en) * 2007-01-09 2009-11-18 Novo Nordisk A/S Urea glucokinase activators
JP5226008B2 (ja) 2007-01-11 2013-07-03 ノボ・ノルデイスク・エー／エス ウレアグルコキナーゼアクチベーター
DE102008014523A1 (de) * 2008-03-15 2009-09-17 Robert Bosch Gmbh Heizgerät
EP2263671B1 (en) * 2008-04-02 2016-07-20 Astellas Pharma Inc. Amide derivative-containing pharmaceutical composition
EP2565191B1 (en) * 2008-05-14 2014-10-08 Astellas Pharma Inc. 4-(Indol-7-ylcarbonylaminomethyl)cyclohexanecarboxylic acid derivatives as EP4 receptor antagonists useful for the treatment of chronic renal failure or diabetic nephropathy
US20110201659A1 (en) * 2008-10-20 2011-08-18 Astellas Pharma Inc. Agent for preventing or treating zoster-associated pain
CN108623577B (zh) * 2018-05-08 2020-09-25 山东百诺医药股份有限公司 阿莫奈韦及其中间体的制备方法
CN112040945A (zh) 2018-06-12 2020-12-04 Vtv治疗有限责任公司 葡萄糖激酶激活剂与胰岛素或胰岛素类似物组合的治疗用途
WO2020038812A1 (en) * 2018-08-20 2020-02-27 Rijksuniversiteit Groningen New process for the preparation of amenamevir
TW202038947A (zh) 2018-11-28 2020-11-01 德商創新分子有限責任公司 在與溶瘤病毒之組合療法中治療癌症的解旋酶引子酶抑制劑
US12391658B2 (en) 2020-02-18 2025-08-19 Vtv Therapeutics Llc Sulfoxide and sulfone glucokinase activators and methods of use thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288091B1 (en) * 1995-12-29 2001-09-11 Boehringer Ingelheim Ltd. Antiherpes virus compounds and methods for their preparation and use
WO1997024343A1 (en) * 1995-12-29 1997-07-10 Boehringer Ingelheim Pharmaceuticals, Inc. Phenyl thiazole derivatives with anti herpes virus properties
WO1999042455A1 (en) * 1998-02-19 1999-08-26 Tularik Inc. Antiviral agents
WO2000029399A1 (en) * 1998-11-12 2000-05-25 Boehringer Ingelheim (Canada) Ltd. Antiherpes compounds
EP1161423B1 (de) * 1999-03-08 2004-11-10 Bayer HealthCare AG Thiazolylharnstoff-derivate und ihre verwendung als antivirale mittel
CA2374947A1 (en) * 1999-05-24 2000-11-30 Robert M. Scarborough Inhibitors of factor xa
JP2003500382A (ja) * 1999-05-24 2003-01-07 シーオーアール セラピューティクス インコーポレイテッド Ｘａ因子の阻害剤
WO2002038554A1 (en) * 2000-11-10 2002-05-16 Yamanouchi Pharmaceutical Co., Ltd. Amide derivatives
DE10139060A1 (de) 2001-08-08 2003-02-20 Merck Patent Gmbh Phenylderivate
AU2003235889A1 (en) 2002-05-09 2003-11-11 Rational Drug Design Laboratories Amide derivatives
TW200505894A (en) * 2003-08-08 2005-02-16 Yamanouchi Pharma Co Ltd Tetrahydro-2H-thiopyran-4-carboxamide derivative

Also Published As

Publication number Publication date
AU2004263448B2 (en) 2009-02-05
BRPI0413430B1 (pt) 2019-04-30
PT1652843E (pt) 2014-06-02
CN1832930A (zh) 2006-09-13
EP1652843A4 (en) 2010-07-28
CA2535199A1 (en) 2005-02-17
NO335467B1 (no) 2014-12-15
JPWO2005014559A1 (ja) 2006-10-05
EP1652843B1 (en) 2014-04-02
TW200505894A (en) 2005-02-16
CN100445271C (zh) 2008-12-24
NO20061100L (no) 2006-03-07
KR101157074B1 (ko) 2012-06-22
ES2462292T3 (es) 2014-05-22
US7465748B2 (en) 2008-12-16
WO2005014559A1 (ja) 2005-02-17
US20050032855A1 (en) 2005-02-10
MXPA06001526A (es) 2006-05-25
KR20060073928A (ko) 2006-06-29
CA2535199C (en) 2010-12-14
US20060229295A1 (en) 2006-10-12
BRPI0413430B8 (pt) 2021-05-25
RU2336273C2 (ru) 2008-10-20
CY1115461T1 (el) 2017-01-04
US6903125B2 (en) 2005-06-07
AU2004263448A1 (en) 2005-02-17
JP4549974B2 (ja) 2010-09-22
DK1652843T3 (da) 2014-05-05
BRPI0413430A (pt) 2006-10-17
TWI341311B (pl) 2011-05-01
RU2006106922A (ru) 2006-08-27
EP1652843A1 (en) 2006-05-03
SI1652843T1 (sl) 2014-06-30

Similar Documents

Publication Publication Date Title
GB0324790D0 (en) Amide derivatives
IL211894A0 (en) Amide derivatives
SI1594840T1 (sl) Derivati piperidin-benzensulfonamida
IL169905A0 (en) Novel 2-pyridinecarboxamide derivatives
GB0317665D0 (en) Qinazoline derivatives
IL183657A0 (en) Amide derivatives
AP1850A (en) Spiroindolineplperidine derivatives
EG24050A (en) Heterocylocarboxamide derivatives
SI1682493T1 (sl) Amidoacetonitrilni derivati
IL204829A0 (en) Aniline derivatives
PL1606277T3 (pl) Pochodne imidazol-4-iloetynylo-pirydyny
TWI368482B (en) New 2-pyridinylethylbenzamide derivatives
EP1652843A4 (en) AMIDE DERIVATIVES
IL176562A0 (en) Amidopyrazole derivative
IL175189A0 (en) N-thiazol-2-yl-benzamide derivatives
GB0329572D0 (en) Amide derivatives
PL1706373T3 (pl) Pochodne amidoacetonitrylu
AU2003222659A8 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
ZA200602131B (en) Amide type carboxamide derivatives
GB2403474B (en) Amide derivatives
GB0312368D0 (en) Novel ureido- and amido-pyrazolone derivatives
AU2003235889A8 (en) Amide derivatives
GB0319793D0 (en) Pyridinylmorpholine derivatives
AU2003243397A8 (en) Homo-camptothecin derivatives
ZA200705150B (en) Amide derivatives